v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 228,713 $ 173,016
Marketable securities, at fair value 67,546 0
Accounts receivable, net 106,843 94,242
Inventories 29,526 14,405
Prepaid assets 11,547 6,327
Other current assets 4,555 2,748
Total current assets 448,730 290,738
Property and equipment (net of accumulated depreciation of $92,895 and $68,809, respectively) 85,873 64,188
Operating lease right-of-use assets 45,786 26,492
Intangible assets, net 120,653 126,640
Goodwill 211,083 198,601
Restricted cash 21,919 0
Prepaid lease asset 20,229 0
Investment in non-consolidated affiliate 29,555 0
Other assets 4,503 2,847
Total non-current assets 539,601 418,768
Total assets 988,331 709,506
Current liabilities    
Accounts payable 24,965 19,568
Accrued compensation 24,727 21,365
Accrued expenses and other liabilities 11,654 7,548
Current portion of equipment financing obligations 2,841 5,432
Current portion of operating lease liabilities 4,967 3,381
Current portion of term loan 0 5,000
Current pharma contract liabilities 4,029 1,610
Total current liabilities 73,183 63,904
Long-term liabilities    
Convertible senior notes, net 168,120 0
Equipment financing obligations 967 3,199
Operating lease liabilities 42,296 24,034
Term loan, net 0 91,829
Deferred income tax liabilities, net 5,415 15,566
Other long-term liabilities 4,056 3,566
Total long-term liabilities 220,854 138,194
Total liabilities 294,037 202,098
Stockholders’ equity    
Common stock, $0.001 par value, (250,000,000 shares authorized; 112,075,474 and 104,781,236 shares issued and outstanding, respectively) 112 105
Additional paid-in capital 701,357 520,278
Accumulated other comprehensive loss 10 (1,618)
Accumulated deficit (7,185) (11,357)
Total stockholders’ equity 694,294 507,408
Total liabilities and stockholders’ equity $ 988,331 $ 709,506

Source